drugset / Trial / NCT06672276
To Evaluate the Pharmacokinetics and Safety of TQD3606 for Injection in Subjects With Renal Insufficiency
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The study is an open, parallel, single-dose phase I clinical study to evaluate the pharmacokinetics and safety of TQD3606 for injection in subjects with renal insufficiency.
Timeline
- Start
- 2024-11-20
- Primary completion
- 2025-05-06
- Completion
- 2025-05-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Meropenem | Small molecule | — | — |
| Comparator | avibactam | Small molecule | — | — |
Indications
No indication recorded.